Books, Journals, New Media Section Editor: Harriet
S. Meyer, MD, Contributing Editor, JAMA; David H. Morse, MS, University
of Southern California, Norris Medical Library, Journal Review Editor; adviser
for new media, Robert Hogan, MD, San Diego.
The time couldn't be better for a book on the ethical issues associated
with biotechnology. Given the extent to which biotechnology affects our daily
lives and the polarized concerns about it expressed in the popular press,
ranging from wholehearted endorsement to apprehensive condemnation, there
has been relatively little serious attention focused on the ethical issues
associated with corporate biotechnology. Biotechnology is driven in large
part by forces in the private sector, yet careful discussions about ethical
issues tend to happen in the academy, typically far removed from the boardrooms
where important decisions are made. In Guiding Icarus: Merging
Bioethics With Corporate Interests, Rahul K. Dhanda, an employee of
a biotechnology company, sets out to bring bioethics to the private sector.
This is a critical task.
Sugarman J. Biotechnology, Bioethics. JAMA. 2003;289(4):490-491. doi:10.1001/jama.289.4.490